These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22000822)

  • 1. Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex.
    Perek-Polnik M; Jóźwiak S; Jurkiewicz E; Perek D; Kotulska K
    Eur J Paediatr Neurol; 2012 Jan; 16(1):83-5. PubMed ID: 22000822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex.
    Goyer I; Dahdah N; Major P
    Pediatr Neurol; 2015 Apr; 52(4):450-3. PubMed ID: 25682485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Everolimus Treatment for an Early Infantile Subependymal Giant Cell Astrocytoma With Tuberous Sclerosis Complex.
    Fukumura S; Watanabe T; Takayama R; Minagawa K; Tsutsumi H
    J Child Neurol; 2015 Aug; 30(9):1192-5. PubMed ID: 25143481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
    Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA
    J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
    Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Whittemore VH; Thiele EA; Ford JP; Shah G; Cauwel H; Lebwohl D; Sahmoud T; Jozwiak S
    Lancet; 2013 Jan; 381(9861):125-32. PubMed ID: 23158522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis.
    Krueger DA; Care MM; Holland K; Agricola K; Tudor C; Mangeshkar P; Wilson KA; Byars A; Sahmoud T; Franz DN
    N Engl J Med; 2010 Nov; 363(19):1801-11. PubMed ID: 21047224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus for the treatment of subependymal giant cell astrocytoma probably causing seizure aggravation in a child with tuberous sclerosis complex: a case report.
    Wiemer-Kruel A; Woerle H; Strobl K; Bast T
    Neuropediatrics; 2014 Apr; 45(2):129-31. PubMed ID: 24293099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oligosymptomatic variant of tuberous sclerosis with subependymal giant cell astrocytoma].
    Rieger E; Binder B; Starz I; Oberbauer R; Urban C
    Padiatr Padol; 1991; 26(1):35-7. PubMed ID: 2057209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Józwiak S; Stein K; Kotulska K
    Future Oncol; 2012 Dec; 8(12):1515-23. PubMed ID: 23231513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting response to everolimus therapy for subependymal giant cell astrocytomas associated with tuberous sclerosis.
    Trelinska J; Dachowska I; Kotulska K; Baranska D; Fendler W; Jozwiak S; Mlynarski W
    Pediatr Blood Cancer; 2015 Apr; 62(4):616-21. PubMed ID: 25557360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?
    Wiegand G; May TW; Ostertag P; Boor R; Stephani U; Franz DN
    Eur J Paediatr Neurol; 2013 Nov; 17(6):631-8. PubMed ID: 23845174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological Findings of a Subependymal Giant Cell Astrocytoma Following Treatment With Rapamycin.
    Cheng S; Hawkins C; Taylor MD; Bartels U
    Pediatr Neurol; 2015 Sep; 53(3):238-242.e1. PubMed ID: 26173783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of subependymal giant cell astrocytoma with spinal cord metastasis to everolimus.
    Aguilera D; Flamini R; Mazewski C; Schniederjan M; Hayes L; Boydston W; Castellino RC; MacDonald TJ
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e448-51. PubMed ID: 24276039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oligosymptomatic Bourneville-Pringle tuberous sclerosis of the brain with giant cell astrocytoma].
    Rieger E; Starz I; Binder B; Oberbauer R; Urban C
    Hautarzt; 1991 Oct; 42(10):638-41. PubMed ID: 1757257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberous sclerosis with intraventricular tumor: report of 2 cases].
    Fukuoka H; Takagi T; Shimazu N; Nagai H
    No Shinkei Geka; 1986 Oct; 14(11):1377-81. PubMed ID: 3808199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus tablets for patients with subependymal giant cell astrocytoma.
    Turner SG; Peters KB; Vredenburgh JJ; Desjardins A; Friedman HS; Reardon DA
    Expert Opin Pharmacother; 2011 Oct; 12(14):2265-9. PubMed ID: 21806479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of subependymal giant cell astrocytoma not associated with tuberous sclerosis].
    Watanabe Y; Oki S; Migita K; Isobe N; Okazaki T; Nabika S
    No Shinkei Geka; 2003 May; 31(5):543-8. PubMed ID: 12755028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent communicating hydrocephalus in adult tuberous sclerosis patients: a possible therapeutic role for everolimus.
    Laviv Y; Jackson S; Rappaport ZH
    Acta Neurochir (Wien); 2015 Feb; 157(2):241-5. PubMed ID: 25524658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.
    Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Berkowitz N; Anak O; Niolat J; Jozwiak S
    Lancet Oncol; 2014 Dec; 15(13):1513-1520. PubMed ID: 25456370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.